* Prophase Labs Inc PRPH.OQ PRPH.O is expected to show a
rise
in quarterly revenue when it reports results on May 13.
* The New York City-based company is expected to report a
59.2% increase in revenue to $24.311 million from $15.27 million
a year ago, according to the mean estimate from 2 analysts,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for Prophase Labs Inc
is for
earnings of 39 cents per share. For the same quarter last year,
the company reported earnings of 27 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts had risen by
about 22.2%
in the last three months.
* Wall Street's median 12-month price target for Prophase
Labs Inc
is $12, above its last closing price of $7.07.
This summary was machine generated May 7 at 02:06 GMT. All
figures in US dollars unless otherwise stated